( August 28, 2025, 12:00 GMT | Official Statement) -- MLex Summary: Plaintiffs Humana, Molina Healthcare, Blue Cross Blue Shield and others moved for dismissal of defendant Hikma from their US antitrust claims over the drug Xyrem pursuant to settlement agreements between the parties. "Legal prejudice is not at issue here ... As indicated, Hikma does not oppose Plaintiffs’ motion, or the proposed order submitted herewith, but rather has requested that Plaintiffs seek its dismissal from their respective cases with prejudice," the plaintiffs' motion to dismiss filed to the Northern District of California said.See attached document....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.